Core Viewpoint - The company plans to reappoint the accounting firm Gongzheng Tianye as its auditor for the fiscal year 2025, pending approval from the shareholders' meeting [1][5]. Group 1: Accounting Firm Information - Gongzheng Tianye was established in 1982 and is one of the first accounting firms approved for securities and futures-related business [1][2]. - As of the end of 2024, Gongzheng Tianye has 59 partners and 349 registered accountants, with 168 of them having signed audit reports for securities services [1][2]. - In 2024, Gongzheng Tianye reported total audited revenue of 308.57 million yuan, with audit business revenue of 265.46 million yuan and securities business revenue of 162.52 million yuan [2]. Group 2: Audit Project Information - The project partner for the audit is Zhou Ying, who has experience with listed company audit reports including those for Maolai Optics [3]. - The signing registered accountant is Jiang Xuejiao, who began providing audit services to the company in 2023 and has signed audit reports for other listed companies [3]. - The quality control reviewer for the project is Xue Min, who will start providing services in 2025 and has experience with other listed companies [3]. Group 3: Audit Committee and Board Approval - The audit committee of the company has reviewed and approved the reappointment of Gongzheng Tianye, citing their professional competence and adherence to independent auditing standards [4]. - The board of directors also approved the proposal to reappoint the accounting firm, which will be submitted to the shareholders' meeting for final approval [4][5].

证券代码：688502 证券简称：茂莱光学 公告编号：2025-061 南京茂莱光学科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 南京茂莱光学科技股份有限公司（以下简称"公司"）于 2025 年 8 月 13 日召开公司第四届董事会第十三次会议、第四届监事会第十二次会议，审议通过 了《关于使用部分超募资金永久补充流动资金的议案》，在保证募集资金投资项 目建设的资金需求和募投项目正常进行的前提下，同意将部分超募资金人民币 保荐机构中国国际金融股份有限公司（以下简称"保荐机构"）对上述事项 出具了无异议的核查意见。该事项尚需经公司股东会审议通过后方可实施，现将 相关情况公告如下： 一、募集资金基本情况 根据中国证券监督管理委员会于 2023 年 1 月 12 日出具的《关于同意南京茂 莱光学科技股份有限公司首次公开发行股票注册的批复》（证监许可〔2023〕84 号），并经上海证券交易所同意，公司获准向社会公开发行人民币普通股 1,320 万股，每股发行价格为人民币 69.72 元，募集资金总额为人民币 92 ...

Core Viewpoint - The company, Nanjing Maolai Optical Technology Co., Ltd., plans to conduct foreign exchange derivative hedging transactions to mitigate foreign exchange risk associated with its overseas business operations, primarily settled in USD, EUR, and GBP [1][2]. Summary by Sections Basic Situation of Foreign Exchange Derivative Hedging Transactions - The purpose of the transactions is to enhance the company's ability to manage foreign exchange market risks and to prevent adverse impacts on its operating performance due to exchange rate fluctuations [1]. - The total amount for the foreign exchange derivative hedging transactions in 2025 is not to exceed 100 million RMB or equivalent foreign currency, with the ability to roll over within 12 months from the date of resolution approval [2]. - The funding source for these transactions will primarily be the company's own funds, without involving raised funds [2]. - The company will utilize simple and transparent derivative instruments such as foreign exchange forwards, options, and swaps, adhering to hedging principles and risk-neutral management [2]. - The effective period for these transactions is 12 months from the board meeting approval [2]. Risk Analysis of Foreign Exchange Derivative Transactions - The company acknowledges potential risks including unforeseen changes in domestic and international economic conditions, counterparty defaults, overdue receivables, and operational errors due to the complexity of foreign exchange derivative transactions [3][4]. Risk Control Measures - The company has established clear internal control systems, including defined responsibilities and risk reporting mechanisms, to manage the foreign exchange hedging activities [4]. Impact and Accounting Treatment of Foreign Exchange Derivative Hedging Transactions - Engaging in foreign exchange hedging is aimed at effectively mitigating risks from foreign exchange market volatility, improving the efficiency of foreign currency usage, and reducing financial costs [4]. - The company will follow relevant accounting standards for financial instruments and hedge accounting to process and disclose the hedging activities in its financial reports [4]. Review Procedures and Opinions - The board of directors and the supervisory board have approved the proposal for foreign exchange derivative hedging transactions, affirming that it will not harm the interests of the company or its shareholders [5]. - The sponsor institution has verified that the proposed hedging activities comply with legal regulations and internal control measures, supporting the company's risk management strategy [5][6].

Group 1 - The company plans to use part of the excess raised funds, amounting to RMB 12,300.00 million, to permanently supplement its working capital, which accounts for 29.90% of the total excess funds raised [5][7][8] - The total amount of excess funds raised by the company is RMB 41,134.18 million, with a remaining balance of RMB 15,270.51 million as of June 30, 2025 [8] - The company has committed to not exceeding 30% of the total excess funds for permanent working capital supplementation within the last 12 months [8] Group 2 - The company has received approval from its board of directors and supervisory board for the use of excess funds, which will be submitted for shareholder meeting approval [7][9] - The use of excess funds is aimed at meeting the company's working capital needs, improving the efficiency of fund utilization, and reducing financial costs [8][9] - The company assures that there will be no change in the purpose of the raised funds and that it will not affect the normal progress of the investment projects [8][9]

证券日报网讯 8月13日晚间，茂莱光学发布公告称，公司拟续聘公证天业会计师事务所（特殊普通合 伙）。 （文章来源：证券日报） ...

Core Viewpoint - Maolai Optics announced the approval of a proposal to engage in foreign exchange derivative hedging transactions to mitigate foreign exchange market risks and enhance financial stability [1] Group 1: Company Actions - The company plans to conduct foreign exchange derivative hedging transactions with banks and financial institutions in 2025, with a total amount not exceeding 100 million RMB or equivalent foreign currency [1] - The funding for these transactions will come from the company's own funds, and it will not involve fundraising or speculative trading for profit [1] - The approved limit for these transactions will be valid for 12 months from the date of the board resolution, allowing for the funds to be used in a rolling manner within the specified limit [1]

Group 1 - The company announced that it will hold its second extraordinary general meeting of shareholders in 2025 on September 12 [1] - The agenda for the meeting includes the proposal to use part of the raised funds to permanently supplement working capital [1]

（文章来源：证券日报） 证券日报网讯 8月13日晚间，茂莱光学发布公告称，公司第四届董事会第十三次会议审议通过了《关于 使用部分闲置自有资金进行委托理财的议案》等多项议案。 ...

证券日报网讯 8月13日晚间，茂莱光学发布公告称，公司第四届监事会第十二次会议审议通过了《关于 使用部分闲置自有资金进行委托理财的议案》等多项议案。 （文章来源：证券日报） ...

Group 1 - Kaizhong Precision plans to invest up to 250 million yuan to establish a subsidiary and build a production base in Thailand, focusing on overseas connector and precision component business [1] - Longbo Technology reported a 60.18% year-on-year increase in net profit for the first half of 2025, with revenue of 122 million yuan, up 18.03% [2] - Dingyang Technology achieved a net profit of 76.88 million yuan in the first half of 2025, a year-on-year increase of 31.54%, with revenue of 279 million yuan, up 24.61% [4] Group 2 - Heng Rui Pharmaceutical received approval for clinical trials of two drugs, SHR-A2102 and Adebeli monoclonal antibody injection [6] - Maolai Optical plans to use up to 100 million yuan of idle funds for entrusted wealth management to improve fund utilization efficiency [8] - Shiji Information signed a major contract with MGM Grand, providing a next-generation cloud-based hotel information management system [7] Group 3 - Yunnan Germanium's subsidiary received a government subsidy of 6.8 million yuan related to revenue [9] - Jizhi Co. received a warning letter from the Zhejiang Securities Regulatory Bureau for failing to disclose significant government subsidies [10] - Dongfang Precision reported a net profit of approximately 397 million yuan for the first half of 2025, a year-on-year increase of 142.52% [11] Group 4 - Aolaide expects a net profit decrease of 68.41% to 72.77% for the first half of 2025, with revenue projected between 270 million and 290 million yuan [12] - Feilong Co. used 111 million yuan of idle funds for cash management through structured deposit products [13] - Anhui Construction won two major projects with a total investment exceeding 6.6 billion yuan [15] Group 5 - Yunnan Germanium's subsidiary received a government subsidy of 6.8 million yuan related to revenue [9] - Jizhi Co. received a warning letter from the Zhejiang Securities Regulatory Bureau for failing to disclose significant government subsidies [10] - Dongfang Precision reported a net profit of approximately 397 million yuan for the first half of 2025, a year-on-year increase of 142.52% [11] Group 6 - China Medical's subsidiary received approval for the listing of fumaric acid volnora raw materials [20] - Huayuan Vaccine's subsidiary received approval for clinical trials of Hib vaccine [29] - Ganfeng Lithium plans to integrate lithium salt lake projects in Argentina and provide financial support of up to 130 million USD [41]